'Our problem is not a budget deficit but a trust deficit. We need to trust our institutions and industries to innovate and lead. That is the way forward for India.'
The Indian Medical Association (IMA) has defended a doctor arrested in connection with cough syrup deaths in Madhya Pradesh, attributing the incident to failures in the drugs regulatory system.
Facing mounting opposition to the introduction of Hindi language in Maharashtra schools from classes 1 to 5, the state cabinet on Sunday decided to withdraw two GRs (government orders) on the implementation of the three-language policy.
'When Dr Murli Manohar Joshi wanted to start a course on astrology, Jayant was the first one to have the courage to stand up and say astrology is not science.' 'That's a very rare quality -- to stand up to authority.'
In a letter faxed to Industrial Policy and Promotion secretary Ajay Dua, Mashelkar said he was "deeply pained by the fact that doubts, explicit or implicit," have been expressed about his "integrity, competence and motives."
The government is under strong pressure from its Left party allies to scrap the Technical Expert Group on Patent Laws headed by R A Mashelkar, former chief of the Council for Scientific and Industrial Research.
Carlos M Correa of Brazil, a patent expert of international repute whose views have been widely quoted by the Mashelkar committee to support its conclusions, has complained of 'misinterpretation' of some quotes from a published article titled 'Integrating Public Health Concerns into Patent Legislation in Developing Countries'.
The Mashelkar panel's recommendation to consider all modifications and variants of new chemical entities (NCEs) as patentable has invited criticism from sections of Indian pharmaceutical industry and public interest organisations
The commerce ministry has allowed the technical expert group headed by former Council of Scientific and Industrial Research Chief R A Mashelkar to correct the "technical inacuracies" in the patent law report and re-submit it within three months.
RSS chief Mohan Bhagwat has said that the date of Ram temple consecration in Ayodhya should be celebrated as "Pratishtha Dwadashi" as it marks the "true independence" of India, which faced "parachakra" (enemy attack) for several centuries. Bhagwat said that the Ram temple movement was not started to oppose anyone, but to awaken the "self" (swa) of Bharat so that the country could stand on its own feet and show the path to the world. He also said that the invaders destroyed temples of the country so that the "self" of India also perishes.
The association of Mashelkar and Mukesh Ambani is not new.
While Ambani, 66, drew nil salary from the company since the 2020-21 fiscal year, other executive directors including his cousins Nikhil and Hital are paid a salary, perquisites, allowances and commission. His three children - twins Akash and Isha (both 31) and Anant (28 years) - will get only a sitting fee and a commission on the profit earned by the firm.
The joint inspections is to ensure the safety, efficacy, and quality of drugs available in the country
Billionaire Mukesh Ambani for the second year in a row drew no salary from his flagship firm Reliance Industries in the last fiscal as he voluntarily gave up remuneration in light of the pandemic hitting the business and economy. In its latest annual report, Reliance said Ambani's remuneration for the financial year 2020-21 was "nil". In June 2020, Mukesh D Ambani, chairman and managing director of Reliance Industries, voluntarily decided to forego his salary for the year 2020-21, in light of the COVID-19 outbreak in India, which exacted a huge toll on the societal, economic and industrial health of the nation.
In the previous fiscal year, he drew a Rs 15 crore salary from the company -- the same as in the previous 11 years.
The decision has come in the wake of allegations of plagiarism against the Mashelkar panel report.
India's R&D spend trebled in a decade, but China's has grown even faster
Eminent scientist R A Mashelkar was on Monday conferred the Padma Vibhushan, the second highest civilian award, while acclaimed artiste Kamal Haasan and ace shuttler P Gopichand were among the 12 personalities conferred the Padma Bhushan by President Pranab Mukherjee in New Delhi.
Noted scientist R A Mashelkar and yoga guru B K S Iyengar were on Saturday chosen for this year's Padma Vibhushan, the second highest civilian honour in India, while cine star Kamala Haasan, author Ruskin Bond and late former chief justice J S Verma were selected for the Padma Bhushan.
'Let me talk about young Indian startups with their hearts in the right place and how they are proving that innovations that represent 'affordable excellence' -- breaking the myth that 'affordability' and 'excellence' cannot go together -- is indeed possible!' says Dr R A Mashelkar, the eminent scientist, in this fascinating feature.
Can we make high speed 4G Internet available at 10 cents per GB, and make all voice calls free of cost -- that too in a large and diverse country like India? Can we make high-quality but simple breast cancer screening available to every woman, that too at the extremely affordable cost of $1 per scan? Can we make a portable, high-tech ECG machine which can provide reports immediately and that too at the cost of 8 cents a test? Can we make an eye imaging device that is portable, non-invasive and costs 3 times less that conventional devices? Can we make a robust test for mosquito-borne dengue, which can detect the disease on day 1, and that too at the cost of $2 per test? Amazingly, says Dr R A Mashelkar, the eminent scientist, all this has been achieved in India, not only by using technological innovation but also non-technological innovation.
N R Narayana Murthy, co-founder and chief mentor of India's second-largest IT services provider Infosys Technologies, is planning to invest in US-based clean technology venture capital fund Siderian Ventures.
Saudi Aramco chairman and head of the Kingdom's cash-rich wealth fund PIF Yasir Othman Al-Rumayyan will join the board of Reliance Industries Ltd as an independent director in a precursor to a $15 billion deal. Reliance chairman and Asia's richest man Mukesh Ambani, who had two years back disclosed the talks to sell a 20 per cent stake in the company's oil-to-chemical unit to Saudi Aramco, announced the appointment of Al-Rumayyan at the company's annual meeting of shareholders. Harvard educated Al-Rumayyan, 51, will replace Yogendra P Trivedi, 92, who has expressed a desire to retire, Ambani said. On the sale of a 20 per cent stake in the O2C business, he said the deal is likely to conclude this year.
Eleven months after RA Mashelkar retired from the leadership of India's apex research body, Council of Scientific and Industrial Research (CSIR), the government on Monday appointed Samir K Brahmachari, director, Institute of Genomics & Integrative Biology (IGIB), New Delhi, as the new chief. Brahmachari will also head the Department of Scientific and Industrial Research (DSIR) as secretary.
The 3-year partnership to set up a pan India initiative to catalyse the country's technology startup ecosystem was signed today by R A Mashelkar, Chairman, GenNext Ventures and Board Member, RIL, and Bhaskar Pramanik, Chairman, Microsoft India.
Rathod, an IP professional attached to a global generic pharmaceutical company, draws hundreds of readers from across the IP space to his genericpharmaceuticals.blogspot.com.
Ranbaxy Laboratories, the biggest member of the Indian Pharmaceutical Alliance, has come out in the open against the alliance's stand on patent issues.
An industry-friendly regulatory mechanism for biotech sector would be put in place by November, Kapil Sibal, Union Minister for Science and Technology, said.
The first meeting of the Joint Parliamentary Committee on pesticide residues in safety standards for soft drinks, fruit juices and other beverages will be held on Tuesday.
They will be honoured by the Third World Academy of Sciences at the 10th General Conference in Brazil in 2006.
The grandson of Leela Mashelkar, Manish, submitted a memorandum addressed to Chief Minister Vilasrao Deshmukh demanding he be paid the compensation.
R A Mashelkar handed over charge of CSIR recently but continues to be the 'face' of Indian science.
GenNext Innovation Hub is also pursuing a new global partnership program to collaborate with organizations in US, Europe and Asia.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances